Evidence map›Paper›PMID 32624688›Full record

ReviewInternational journal of medical sciences2020

The Process of Osteoblastic Infection by

Qiangqiang Wen, Feng Gu, Zhenjiang Sui, Zilong Su, Tiecheng Yu

Abstract readReview
In one paragraph

Review in International journal of medical sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Intracellular survival ofVirulence · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Dual function ofFrontiers in microbiology · 2025
    Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Qiangqiang WenDepartment of Orthopedics, First Hospital of Jilin University, Changchun 130021, Jilin, China.
Feng GuDepartment of Orthopedics, First Hospital of Jilin University, Changchun 130021, Jilin, China.
Zhenjiang SuiDepartment of Orthopedics, First Hospital of Jilin University, Changchun 130021, Jilin, China.
Zilong SuDepartment of Orthopedics, First Hospital of Jilin University, Changchun 130021, Jilin, China.
Tiecheng YuDepartment of Orthopedics, First Hospital of Jilin University, Changchun 130021, Jilin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone infection is difficult to cure, and relapse frequently occurs, which is a major treatment problem. One of the main reasons for the refractory and recurrent nature of bone infection is that bacteria, such as Staphylococcus aureus (S. aureus), can be internalized into osteoblasts after infecting bone tissue, thereby avoiding attack by the immune system and antibiotics. Understanding how bacteria (such as S. aureus) are internalized into osteoblasts is key to effective treatment. S. aureus is the most common pathogenic bacterium that causes bone infection. This paper reviews the literature, analyzes the specific process of osteoblastic S. aureus infection, and summarizes specific treatment strategies to improve bone infection treatment.

Indexed as

AnimalsAnti-Bacterial AgentsCells, CulturedHumansOsteoblastsStaphylococcal InfectionsStaphylococcus aureusAnti-Bacterial AgentsAntimicrobial PeptidesInfectionOsteoblasticStaphylococcus Aureus

Identifiers

PMID32624688
PMCPMC7330672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.